Devices and Other Products

Chrisandra Shufelt, MD, on cardiovascular risk assessment and menopause care

FDA removes boxed warnings from 3 more menopausal hormone therapy products

Study does not support dose reduction to prevent severe NOWS

Susan Reed, MD, on the future of menopause research and funding

Chrisandra Shufelt, MD, on cardiovascular prevention at menopause

Matthew Nudy, MD, on estrogen and the cardiovascular system

ACOG advises against GLP-1 receptor agonists during pregnancy

Rhonda Voskuhl, MD, on estriol for cognitive symptoms of menopause

Multi-society framework ties cardiovascular risk to female life stages

Mind, Body, & the Pause: Menopause, brain fog, and screening gaps, with Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG